Evommune, Inc. (EVMN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for EVMN. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 101 institutions reported holding EVMN, with 34.6 million shares worth $462.5 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Eqt Fund Management S.a R.L | 5,288,313 | $70M | INCREASED |
| RA Capital Management, | 3,494,638 | $46M | UNCHANGED |
| T. Rowe Price | 1,940,939 | $26M | INCREASED |
| Pivotal Bioventure Partners Investment Advisor | 1,926,943 | $26M | UNCHANGED |
| JPMorgan Chase | 1,553,132 | $23M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Evommune, Inc. on SentiSense.